{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:50:40Z","timestamp":1768711840724,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00406-018-0965-4","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T17:20:24Z","timestamp":1544548824000},"page":"931-940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine"],"prefix":"10.1007","volume":"269","author":[{"given":"Daniela","family":"Mier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1700-0958","authenticated-orcid":false,"given":"Frederike","family":"Schirmbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Stoessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Esslinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Englisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Eisenacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meyer-Lindenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Zink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"965_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/schbul\/sbp148","volume":"37","author":"A Achim","year":"2011","unstructured":"Achim A, Maziade M, Raymond E, Olivier D, Merette C, Roy M (2011) How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 37:811\u2013821","journal-title":"Schizophr Bull"},{"issue":"2\u20133","key":"965_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.schres.2013.10.033","volume":"152","author":"M Swets","year":"2014","unstructured":"Swets M, Dekker J, van Emmerik-van Oortmerssen K, Smid GE, Smit F, de Haan L, Schoevers RA (2014) The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res 152(2\u20133):458\u2013468. https:\/\/doi.org\/10.1016\/j.schres.2013.10.033","journal-title":"Schizophr Res"},{"issue":"3","key":"965_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1751-7893.2012.00377.x","volume":"7","author":"L Haan de","year":"2013","unstructured":"de Haan L, Sterk B, van der Valk R (2013) Presence of obsessive compulsive symptoms in first-episode schizophrenia or related disorders is associated with subjective well-being and quality of life. Early Interv Psychiatry 7(3):285\u2013290","journal-title":"Early Interv Psychiatry"},{"key":"965_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-12952-5_6","volume-title":"Obsessive\u2013compulsive symptoms in schizophrenia","author":"H Hunter","year":"2015","unstructured":"Hunter H, Lysaker P (2015) Associations of comorbid obsessive\u2013compulsive symptoms with psychotic and affective symptoms and general functioning. In: De Haan L, Schirmbeck F, Zink M (eds) Obsessive\u2013compulsive symptoms in schizophrenia. Springer, Berlin, pp\u00a077\u201388. https:\/\/doi.org\/10.1007\/978-3-319-12952-5_6"},{"key":"965_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.schres.2006.09.023","volume":"90","author":"L Sevincok","year":"2007","unstructured":"Sevincok L, Akoglu A, Kokcu F (2007) Suicidality in schizophrenic patients with and without obsessive\u2013compulsive disorder. Schizophr Res 90:198\u2013202","journal-title":"Schizophr Res"},{"issue":"12","key":"965_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1097\/00005053-199012000-00006","volume":"178","author":"WS Fenton","year":"1990","unstructured":"Fenton WS, McGlashan TH (1990) Long-term outcome of obsessive\u2013compulsive disorder with psychotic features. J Nerv Ment Dis 178(12):760\u2013761","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"965_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/schbul\/sbr077","volume":"39","author":"L Haan de","year":"2012","unstructured":"de Haan L, Sterk B, Wouters L, Linszen DH (2012) The 5-year course of obsessive\u2013compulsive symptoms and obsessive\u2013compulsive disorder in first-episode schizophrenia and related disorders. Schizophr Bull 39(1):151\u2013160","journal-title":"Schizophr Bull"},{"key":"965_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-319-12952-5_4","volume-title":"Obsessive\u2013compulsive symptoms in schizophrenia","author":"F Schirmbeck","year":"2015","unstructured":"Schirmbeck F, Swets M, de Haan L (2015) Epidemiology: prevalence and clinical characteristics of obsessive\u2013compulsive disorder and obsessive\u2013compulsive symptoms in patients with psychotic disorders. In: De Haan L, Schirmbeck F, Zink M (eds) Obsessive\u2013compulsive symptoms in schizophrenia. Springer, Berlin, pp\u00a047\u201361. https:\/\/doi.org\/10.1007\/978-3-319-12952-5_4"},{"key":"965_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.psychres.2016.09.031","volume":"246","author":"D Grillault Laroche","year":"2016","unstructured":"Grillault Laroche D, Gaillard A (2016) Induced Obsessive compulsive symptoms (OCS) in schizophrenia patients under Atypical 2 antipsychotics (AAPs): review and hypotheses. Psychiatry Res 246:119\u2013128. https:\/\/doi.org\/10.1016\/j.psychres.2016.09.031","journal-title":"Psychiatry Res"},{"key":"965_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-319-12952-5_10","volume-title":"Obsessive\u2013compulsive symptoms in schizophrenia","author":"F Schirmbeck","year":"2015","unstructured":"Schirmbeck F, Zink M (2015) Effects of antipsychotic treatment on obsessive\u2013compulsive symptoms. In: De Haan L, Schirmbeck F, Zink M (eds) Obsessive\u2013compulsive symptoms in schizophrenia. Springer, Berlin, pp\u00a0147\u2013175. https:\/\/doi.org\/10.1007\/978-3-319-12952-5_10"},{"issue":"2","key":"965_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4088\/JCP.v63n0203","volume":"63","author":"L Haan de","year":"2002","unstructured":"de Haan L, Beuk N, Hoogenboom B, Dingemans P, Linszen D (2002) Obsessive\u2013compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry 63(2):104\u2013107","journal-title":"J Clin Psychiatry"},{"key":"965_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0079-6123(08)00910-2","volume":"172","author":"T Kuroki","year":"2008","unstructured":"Kuroki T, Nagao N, Nakahara T (2008) Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Prog Brain Res 172:199\u2013212. https:\/\/doi.org\/10.1016\/s0079-6123(08)00910-2","journal-title":"Prog Brain Res"},{"key":"965_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0079-6123(08)00909-6","volume":"172","author":"HY Meltzer","year":"2008","unstructured":"Meltzer HY, Huang M (2008) In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog Brain Res 172:177\u2013197","journal-title":"Prog Brain Res"},{"issue":"Suppl 2","key":"965_CR14","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/00004850-199705002-00006","volume":"12","author":"B Scatton","year":"1997","unstructured":"Scatton B, Claustre Y, Cudennec A, Oblin A, Perrault G, Sanger DJ, Schoemaker H (1997) Amisulpride: from animal pharmacology to therapeutic action [review]. Int Clin Psychopharmacol 12(Suppl 2):S29\u2013S36","journal-title":"Int Clin Psychopharmacol"},{"issue":"11","key":"965_CR15","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.4088\/JCP.09r05060gre","volume":"71","author":"A Sparshatt","year":"2010","unstructured":"Sparshatt A, Taylor D, Patel MX, Kapur S (2010) A systematic review of aripiprazole\u2013dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring. J Clin Psychiatry 71(11):1447\u20131456","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"965_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4088\/JCP.v66n0107","volume":"66","author":"KM Connor","year":"2005","unstructured":"Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR (2005) The use of aripiprazole in obsessive\u2013compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry 66(1):49\u201351","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"965_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/JCP.0b013e318172755a","volume":"28","author":"SW Kim","year":"2008","unstructured":"Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS (2008) Amisulpride improves obsessive\u2013compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study. J Clin Psychopharmacol 28(3):349\u2013352","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"965_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/JCP.0b013e31820e3db6","volume":"31","author":"MR Muscatello","year":"2011","unstructured":"Muscatello MR, Bruno A, Pandolfo G, Mico U, Scimeca G, Romeo VM, Santoro V, Settineri S, Spina E, Zoccali RA (2011) Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive\u2013compulsive disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 31(2):174\u2013179","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"965_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/00048670601172806","volume":"41","author":"M Zink","year":"2006","unstructured":"Zink M, Knopf U, Kuwilsky A (2006) Management of clozapine-induced obsessive compulsive symptoms in a man with schizophrenia. Aust N Z J Psychiatry 41(3):293\u2013294","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"965_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/WNF.0b013e31819cc8e6","volume":"32","author":"S Englisch","year":"2009","unstructured":"Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A, Schirmbeck F, Zink M (2009) Clozapine-induced obsessive compulsive syndromes improve in combination with aripiprazole. Clin Neuropharmacol 32(4):227\u2013229","journal-title":"Clin Neuropharmacol"},{"key":"965_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000141922","volume":"41","author":"M Zink","year":"2008","unstructured":"Zink M, Englisch S, Dressing H (2008) Neurobiology confirms psychopathology: on the antagonism of psychosis and obsessive\u2013compulsive syndromes. Psychopathology 41:279\u2013285","journal-title":"Psychopathology"},{"issue":"4","key":"965_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/15622970802465807","volume":"9","author":"B Bandelow","year":"2008","unstructured":"Bandelow B, Zohar J, Hollander E, Kasper S, ller HJ, WFSBP Task Force on Treatment Guidelines for Anxiety O-CaP-TSD, Zohar J, Hollander E, Kasper S, ller HJ, Bandelow B, Allgulander C, yuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, pine Liebowitz JP, Lopez-Ibor MR, Marazziti JJ, Miguel D, Oh EC, Preter KS, Rupprecht M, Sato R, Starcevic M, Stein V, DJ, van AM, Vega J (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive\u2013compulsive and post-traumatic stress disorders\u2014first revision. World J Biol Psychiatry 9(4):248\u2013312","journal-title":"World J Biol Psychiatry"},{"key":"965_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-3-319-12952-5_11","volume-title":"Obsessive\u2013compulsive symptoms in schizophrenia","author":"S Englisch","year":"2015","unstructured":"Englisch S, Zink M (2015) Polypharmacy for obsessive\u2013compulsive symptoms in schizophrenia: augmentation and combination strategies. In: De Haan L, Schirmbeck F, Zink M (eds) Obsessive\u2013compulsive symptoms in schizophrenia. Springer, Berlin, pp\u00a0179\u2013202. https:\/\/doi.org\/10.1007\/978-3-319-12952-5_11"},{"issue":"3","key":"965_CR24","first-page":"448","volume":"20","author":"CH R\u00f6der","year":"2013","unstructured":"R\u00f6der CH, Dieleman S, van der Veen FM, Linden D (2013) Systematic review of the influence of antipsychotics on the blood oxygenation level-dependent signal of functional magnetic resonance imaging. Curr Med Chem 20(3):448\u2013461","journal-title":"Curr Med Chem"},{"issue":"11","key":"965_CR25","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1017\/S0033291711000419","volume":"41","author":"F Schirmbeck","year":"2011","unstructured":"Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M (2011) Antiserotonergic antipsychotics are associated with obsessive\u2013compulsive symptoms in schizophrenia. Psychol Med 41(11):2361\u20132374","journal-title":"Psychol Med"},{"issue":"4","key":"965_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/0269881112463470","volume":"27","author":"F Schirmbeck","year":"2013","unstructured":"Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M (2013) Differential effects of antipsychotic agents on obsessive\u2013compulsive symptoms in schizophrenia: a longitudinal study. J Psychopharmacol 27(4):349\u2013357","journal-title":"J Psychopharmacol"},{"issue":"2","key":"965_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1503\/jpn.140021","volume":"40","author":"F Schirmbeck","year":"2015","unstructured":"Schirmbeck F, Mier D, Esslinger C, Rausch F, Englisch S, Eifler S, Meyer-Lindenberg A, Kirsch P, Zink M (2015) Increased orbitofrontal cortex activation associated with \u201cpro-obsessive\u201d antipsychotic treatment in patients with schizophrenia. J Psychiatry Neurosci J Psychiatry Neurosci 40(2):89\u201399","journal-title":"J Psychiatry Neurosci J Psychiatry Neurosci"},{"issue":"1","key":"965_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1034\/j.1600-0447.2000.102001032.x","volume":"102","author":"F Aoyama","year":"2000","unstructured":"Aoyama F, Iida J, Inoue M, Iwasaka H, Sakiyama S, Hata K, Kishimoto T (2000) Brain imaging in childhood- and adolescence-onset schizophrenia associated with obsessive\u2013compulsive symptoms. Acta Psychiatr Scand 102(1):32\u201337","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"965_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eurpsy.2013.02.004","volume":"29","author":"M Bleich-Cohen","year":"2014","unstructured":"Bleich-Cohen M, Hendler T, Weizman R, Faragian S, Weizman A, Poyurovsky M (2014) Working memory dysfunction in schizophrenia patients with obsessive\u2013compulsive symptoms: an fMRI study. Eur Psychiatry 29(3):160\u2013166. https:\/\/doi.org\/10.1016\/j.eurpsy.2013.02.004","journal-title":"Eur Psychiatry"},{"issue":"5","key":"965_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0010-440X(98)90040-2","volume":"39","author":"JB Levine","year":"1998","unstructured":"Levine JB, Gruber SA, Baird AA, Yurgelun-Todd D (1998) Obsessive\u2013compulsive disorder among schizophrenic patients: an exploratory study using functional magnetic resonance imaging data. Compr Psychiatry 39(5):308\u2013311","journal-title":"Compr Psychiatry"},{"issue":"9\u201310","key":"965_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/s-2006-952021","volume":"57","author":"G Schiepek","year":"2007","unstructured":"Schiepek G, Tominschek I, Karch S, Mulert C, Pogarell O (2007) Neuroimaging and the neurobiology of obsessive\u2013compulsive disorder. Psychotherapie Psychosomatik medizinische Psychologie 57(9\u201310):379\u2013394. https:\/\/doi.org\/10.1055\/s-2006-952021","journal-title":"Psychotherapie Psychosomatik medizinische Psychologie"},{"issue":"2","key":"965_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0896-6273(00)00113-6","volume":"28","author":"AM Graybiel","year":"2000","unstructured":"Graybiel AM, Rauch SL (2000) Toward a neurobiology of obsessive\u2013compulsive disorder. Neuron 28(2):343\u2013347","journal-title":"Neuron"},{"issue":"3","key":"965_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bpsc.2015.12.004","volume":"1","author":"A MacNamara","year":"2016","unstructured":"MacNamara A, DiGangi J, Phan KL (2016) Aberrant spontaneous and task-dependent functional connections in the anxious brain. Biol Psychiatry Cogn Neurosci Neuroimaging 1(3):278\u2013287. https:\/\/doi.org\/10.1016\/j.bpsc.2015.12.004","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"5","key":"965_CR34","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.euroneuro.2015.12.005","volume":"26","author":"OA Heuvel van den","year":"2016","unstructured":"van den Heuvel OA, van Wingen G, Soriano-Mas C, Alonso P, Chamberlain SR, Nakamae T, Denys D, Goudriaan AE, Veltman DJ (2016) Brain circuitry of compulsivity. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 26(5):810\u2013827. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.12.005","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"1","key":"965_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","volume":"16","author":"MR Milad","year":"2012","unstructured":"Milad MR, Rauch SL (2012) Obsessive\u2013compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 16(1):43\u201351. https:\/\/doi.org\/10.1016\/j.tics.2011.11.003","journal-title":"Trends Cogn Sci"},{"issue":"35","key":"965_CR36","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1523\/jneurosci.0170-13.2013","volume":"33","author":"YT Cho","year":"2013","unstructured":"Cho YT, Ernst M, Fudge JL (2013) Cortico\u2013amygdala\u2013striatal circuits are organized as hierarchical subsystems through the primate amygdala. J Neurosci 33(35):14017\u201314030. https:\/\/doi.org\/10.1523\/jneurosci.0170-13.2013","journal-title":"J Neurosci"},{"key":"965_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnsys.2015.00171","volume":"9","author":"J Wood","year":"2015","unstructured":"Wood J, Ahmari SE (2015) A framework for understanding the emerging role of corticolimbic-ventral striatal networks in OCD-associated repetitive behaviors. Front Syst Neurosci 9:171. https:\/\/doi.org\/10.3389\/fnsys.2015.00171","journal-title":"Front Syst Neurosci"},{"issue":"1","key":"965_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1192\/bjp.bp.112.123364","volume":"204","author":"E Via","year":"2014","unstructured":"Via E, Cardoner N, Pujol J, Alonso P, Lopez-Sola M, Real E, Contreras-Rodriguez O, Deus J, Segalas C, Menchon JM, Soriano-Mas C, Harrison BJ (2014) Amygdala activation and symptom dimensions in obsessive\u2013compulsive disorder. Br J Psychiatry 204(1):61\u201368. https:\/\/doi.org\/10.1192\/bjp.bp.112.123364","journal-title":"Br J Psychiatry"},{"issue":"5","key":"965_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/15622975.2011.559268","volume":"12","author":"N Cardoner","year":"2011","unstructured":"Cardoner N, Harrison BJ, Pujol J, Soriano-Mas C, Hernandez-Ribas R, Lopez-Sola M, Real E, Deus J, Ortiz H, Alonso P, Menchon JM (2011) Enhanced brain responsiveness during active emotional face processing in obsessive compulsive disorder. World J Biol Psychiatry Off J World Feder Soc Biol Psychiatry 12(5):349\u2013363. https:\/\/doi.org\/10.3109\/15622975.2011.559268","journal-title":"World J Biol Psychiatry Off J World Feder Soc Biol Psychiatry"},{"issue":"7","key":"965_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/da.20718","volume":"27","author":"JC Britton","year":"2010","unstructured":"Britton JC, Stewart SE, Killgore WD, Rosso IM, Price LM, Gold AL, Pine DS, Wilhelm S, Jenike MA, Rauch SL (2010) Amygdala activation in response to facial expressions in pediatric obsessive\u2013compulsive disorder. Depress Anxiety 27(7):643\u2013651. https:\/\/doi.org\/10.1002\/da.20718","journal-title":"Depress Anxiety"},{"issue":"12","key":"965_CR41","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.biopsych.2004.09.029","volume":"56","author":"PA Cannistraro","year":"2004","unstructured":"Cannistraro PA, Wright CI, Wedig MM, Martis B, Shin LM, Wilhelm S, Rauch SL (2004) Amygdala responses to human faces in obsessive\u2013compulsive disorder. Biol Psychiatry 56(12):916\u2013920. https:\/\/doi.org\/10.1016\/j.biopsych.2004.09.029","journal-title":"Biol Psychiatry"},{"issue":"5","key":"965_CR42","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/schbul\/sbq168","volume":"38","author":"A Anticevic","year":"2012","unstructured":"Anticevic A, Repovs G, Barch DM (2012) Emotion effects on attention, amygdala activation, and functional connectivity in schizophrenia. Schizophr Bull 38(5):967\u2013980. https:\/\/doi.org\/10.1093\/schbul\/sbq168","journal-title":"Schizophr Bull"},{"issue":"6","key":"965_CR43","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/schbul\/sbx004","volume":"43","author":"VM Goghari","year":"2017","unstructured":"Goghari VM, Sanford N, Spilka MJ, Woodward TS (2017) Task-related functional connectivity analysis of emotion discrimination in a family study of schizophrenia. Schizophr Bull 43(6):1348\u20131362. https:\/\/doi.org\/10.1093\/schbul\/sbx004","journal-title":"Schizophr Bull"},{"issue":"5","key":"965_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/schbul\/sbn190","volume":"36","author":"H Li","year":"2010","unstructured":"Li H, Chan RCK, McAlonan GM, Gong Q-y (2010) Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data. Schizophr Bull 36(5):1029\u20131039. https:\/\/doi.org\/10.1093\/schbul\/sbn190","journal-title":"Schizophr Bull"},{"issue":"3","key":"965_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pscychresns.2013.12.001","volume":"221","author":"D Mier","year":"2014","unstructured":"Mier D, Lis S, Zygrodnik K, Sauer C, Ulferts J, Gallhofer B, Kirsch P (2014) Evidence for altered amygdala activation in schizophrenia in an adaptive emotion recognition task. Psychiatry Res 221(3):195\u2013203. https:\/\/doi.org\/10.1016\/j.pscychresns.2013.12.001","journal-title":"Psychiatry Res"},{"key":"965_CR46","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1017\/S0033291709992133","volume":"40","author":"D Mier","year":"2010","unstructured":"Mier D, Sauer C, Lis S, Esslinger C, Wilhelm J, Gallhofer B, Kirsch P (2010) Neuronal correlates of affective theory of mind in schizophrenia out-patients: evidence for a baseline deficit. Psychol Med 40:1607\u20131617","journal-title":"Psychol Med"},{"key":"965_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neubiorev.2016.08.031","volume":"71","author":"K Raab","year":"2016","unstructured":"Raab K, Kirsch P, Mier D (2016) Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: a review of the imaging literature. Neurosci Biobehav Rev 71:176\u2013197. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.08.031","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"965_CR48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.euroneuro.2011.12.008","volume":"22","author":"EJ Liemburg","year":"2012","unstructured":"Liemburg EJ, Knegtering H, Klein HC, Kortekaas R, Aleman A (2012) Antipsychotic medication and prefrontal cortex activation: a review of neuroimaging findings. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 22(6):387\u2013400. https:\/\/doi.org\/10.1016\/j.euroneuro.2011.12.008","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"12 Suppl","key":"965_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00004850-199705002-00006","volume":"2","author":"B Scatton","year":"1997","unstructured":"Scatton B, Claustre Y, Cudennec A, Oblin A, Perrault G, Sanger DJ, Schoemaker H (1997) Amisulpride: from animal pharmacology to therapeutic action. Int Clin Psychopharmacol 2(12 Suppl):29\u201336","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"965_CR50","first-page":"25","volume":"39","author":"L Haan de","year":"2006","unstructured":"de Haan L, Hoogeboom B, Beuk N, Wouters L, Dingemans PM, Linszen DH (2006) Reliability and validity of the Yale\u2013Brown Obsessive\u2013Compulsive Scale in schizophrenia patients. Psychopharmacol Bull 39(1):25\u201330","journal-title":"Psychopharmacol Bull"},{"issue":"2\u20133","key":"965_CR51","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.psychres.2010.07.048","volume":"186","author":"L Boyette","year":"2011","unstructured":"Boyette L, Swets M, Meijer C, Wouters L, authors GROUP (2011) Factor structure of the Yale\u2013Brown Obsessive\u2013Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive\u2013compulsive symptoms. Psychiatry Res 186(2\u20133):409\u2013413. https:\/\/doi.org\/10.1016\/j.psychres.2010.07.048","journal-title":"Psychiatry Res"},{"issue":"11","key":"965_CR52","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C (1989) The Yale\u2013Brown obsessive compulsive scale: I. Development, use, and reliability. Arch Gen Psychiatry 46(11):1006\u20131011","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"965_CR53","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/nimg.2002.1179","volume":"17","author":"AR Hariri","year":"2002","unstructured":"Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR (2002) The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 17(1):317\u2013323","journal-title":"Neuroimage"},{"key":"965_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejphar.2016.04.013","volume":"781","author":"M Kawano","year":"2016","unstructured":"Kawano M, Oshibuchi H, Kawano T, Muraoka H, Tsutsumi T, Yamada M, Inada K, Ishigooka J (2016) Dopamine dynamics during emotional cognitive processing: implications of the specific actions of clozapine compared with haloperidol. Eur J Pharmacol 781:148\u2013156. https:\/\/doi.org\/10.1016\/j.ejphar.2016.04.013","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"965_CR55","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.neuroscience.2009.09.041","volume":"164","author":"M Han","year":"2009","unstructured":"Han M, Huang XF, du Bois TM, Deng C (2009) The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain. Neuroscience 164(4):1754\u20131763. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.09.041","journal-title":"Neuroscience"},{"key":"965_CR56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.nicl.2014.03.011","volume":"4","author":"D Simon","year":"2014","unstructured":"Simon D, Adler N, Kaufmann C, Kathmann N (2014) Amygdala hyperactivation during symptom provocation in obsessive\u2013compulsive disorder and its modulation by distraction. NeuroImage Clin 4:549\u2013557. https:\/\/doi.org\/10.1016\/j.nicl.2014.03.011","journal-title":"NeuroImage Clin"},{"key":"965_CR57","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.nicl.2016.12.007","volume":"13","author":"OG Rus","year":"2017","unstructured":"Rus OG, Reess TJ, Wagner G, Zimmer C, Zaudig M, Koch K (2017) Functional and structural connectivity of the amygdala in obsessive\u2013compulsive disorder. NeuroImage Clin 13:246\u2013255. https:\/\/doi.org\/10.1016\/j.nicl.2016.12.007","journal-title":"NeuroImage Clin"},{"issue":"10","key":"965_CR58","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1002\/hbm.22898","volume":"36","author":"LS Velzen van","year":"2015","unstructured":"van Velzen LS, de Wit SJ, \u0106ur\u0109i\u0107-Blake B, Cath DC, de Vries FE, Veltman DJ, van der Werf YD, van den Heuvel OA (2015) Altered inhibition-related frontolimbic connectivity in obsessive\u2013compulsive disorder. Human brain mapping 36(10):4064\u20134075. https:\/\/doi.org\/10.1002\/hbm.22898","journal-title":"Human brain mapping"},{"issue":"11","key":"965_CR59","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1002\/hbm.22574","volume":"35","author":"M Gottlich","year":"2014","unstructured":"Gottlich M, Kramer UM, Kordon A, Hohagen F, Zurowski B (2014) Decreased limbic and increased fronto-parietal connectivity in unmedicated patients with obsessive\u2013compulsive disorder. Hum Brain Map 35(11):5617\u20135632. https:\/\/doi.org\/10.1002\/hbm.22574","journal-title":"Hum Brain Map"},{"issue":"6","key":"965_CR60","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1002\/hbm.22371","volume":"35","author":"J Posner","year":"2014","unstructured":"Posner J, Marsh R, Maia TV, Peterson BS, Gruber A, Simpson HB (2014) Reduced functional connectivity within the limbic cortico-striato-thalamo-cortical loop in unmedicated adults with obsessive\u2013compulsive disorder. Hum Brain Map 35(6):2852\u20132860. https:\/\/doi.org\/10.1002\/hbm.22371","journal-title":"Hum Brain Map"},{"issue":"4","key":"965_CR61","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.biopsych.2012.10.006","volume":"73","author":"BJ Harrison","year":"2013","unstructured":"Harrison BJ, Pujol J, Cardoner N, Deus J, Alonso P, Lopez-Sola M, Contreras-Rodriguez O, Real E, Segalas C, Blanco-Hinojo L, Menchon JM, Soriano-Mas C (2013) Brain corticostriatal systems and the major clinical symptom dimensions of obsessive\u2013compulsive disorder. Biol Psychiatry 73(4):321\u2013328. https:\/\/doi.org\/10.1016\/j.biopsych.2012.10.006","journal-title":"Biol Psychiatry"},{"issue":"2\u20133","key":"965_CR62","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pscychresns.2012.02.002","volume":"203","author":"R Admon","year":"2012","unstructured":"Admon R, Bleich-Cohen M, Weizmant R, Poyurovsky M, Faragian S, Hendler T (2012) Functional and structural neural indices of risk aversion in obsessive\u2013compulsive disorder (OCD). Psychiatry Res 203(2\u20133):207\u2013213. https:\/\/doi.org\/10.1016\/j.pscychresns.2012.02.002","journal-title":"Psychiatry Res"},{"key":"965_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.nicl.2013.06.013","volume":"3","author":"WH Jung","year":"2013","unstructured":"Jung WH, Kang DH, Kim E, Shin KS, Jang JH, Kwon JS (2013) Abnormal corticostriatal-limbic functional connectivity in obsessive\u2013compulsive disorder during reward processing and resting-state. NeuroImage Clin 3:27\u201338. https:\/\/doi.org\/10.1016\/j.nicl.2013.06.013","journal-title":"NeuroImage Clin"},{"issue":"12","key":"965_CR64","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1517\/17460441.2013.845553","volume":"8","author":"MA Grados","year":"2013","unstructured":"Grados MA, Specht MW, Sung HM, Fortune D (2013) Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach. Expert Opin Drug Disc 8(12):1515\u20131527. https:\/\/doi.org\/10.1517\/17460441.2013.845553","journal-title":"Expert Opin Drug Disc"},{"issue":"1","key":"965_CR65","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/157015912799362724","volume":"10","author":"F Schirmbeck","year":"2012","unstructured":"Schirmbeck F, Zink M (2012) Clozapine-induced obsessive\u2013compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol 10(1):88\u201395","journal-title":"Curr Neuropharmacol"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-018-0965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-018-0965-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-018-0965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:43:17Z","timestamp":1662597797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-018-0965-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["965"],"URL":"https:\/\/doi.org\/10.1007\/s00406-018-0965-4","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"assertion":[{"value":"17 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Al participants provided written informed consent prior to their inclusion in the study. The study was approved by the accredited Medical Ethics Review Committee (METC) and has therefore been performed in accordance with the ethical standards laid down in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"F. Schirmbeck was supported by a PhD fellowship of the Evangelisches Studienwerk and by a fellowship within the Postdoc-Programme of the German Academic Exchange Service (DAAD). D. Mier was funded by the Olympia-Morata Program. S. Eisenacher was supported by a research grant of the Landesgraduiertenf\u00f6rderung of the Heidelberg University. S. Englisch has received travel expenses and consultant fees from AstraZeneca, Bristol-Myers Squibb GmbH & CoKGaA, Eli-Lilly, Janssen Cilag, Otsuka Pharma, Pfizer Pharma and Servier. A. Meyer-Lindenberg received consultant fees and travel expenses from AstraZeneca, Hoffmann-La Roche and Lundbeck Foundation and speaker\u2019s fees from Pfizer Pharma, Lilly Deutschland, Glaxo SmithKline, Janssen Cilag, Bristol-Myers Squibb, Lundbeck, Servier and AstraZeneca. M. Zink received unrestricted scientifc grants of the European Research Advisory Board (ERAB), German Research Foundation (DFG), Pfizer Pharma GmbH, Servier and Bristol Myers Squibb Pharmaceuticals; further speaker and travel grants were provided from Astra Zeneca, Lilly, Pfizer Pharma GmbH, Bristol Myers Squibb Pharmaceuticals, Otsuka, Servier, Lundbeck and Janssen Cilag. M. Zink, A. Meyer-Lindenberg and P. Kirsch were funded by the Deutsche Forschungsgesellschaft (DFG,, projects ZI1253\/3-1, ZI1253\/3-2, KI 576\/14-2, ME 1591\/6-2). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}